- Home
- VRRM vs NEO Comparison
VRRM vs NEO Comparison
Compare VRRM & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRRM | NEO |
|---|---|---|
| Founded | 1987 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2016 | 2008 |
Fundamental Metrics
Financial Performance| Metric | VRRM | NEO |
|---|---|---|
| Price | $2.90 | $16.54 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 12 |
| Target Price | $6.40 | ★ $21.85 |
| AVG Volume (30 Days) | ★ 6.5M | 2.3M |
| Earning Date | 10-30-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 347.37 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $132,969,000.00 | N/A |
| Revenue This Year | N/A | $10.71 |
| Revenue Next Year | N/A | $9.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 14.61 | N/A |
| 52 Week Low | $2.62 | $7.07 |
| 52 Week High | $25.45 | $20.15 |
Technical Indicators
Market Signals| Indicator | VRRM | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 32.12 | 43.04 |
| Support Level | $2.77 | $15.57 |
| Resistance Level | $4.75 | $16.92 |
| Average True Range (ATR) | 0.16 | 0.98 |
| MACD | 0.05 | -0.18 |
| Stochastic Oscillator | 53.70 | 23.00 |
Price Performance
Historical ComparisonAbout VRRM Verra Mobility Corporation
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe, and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three reportable segments: Commercial Services, Government Solutions, and Parking Solutions. Maximum revenue is generated from the Commercial Services segment, which offers toll and violation management solutions and title and registration services for commercial fleet customers, including RACs and FMCs in North America. In Europe, it provides tolling and violations processing services.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.